Saba Abdulmunem Habeeb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saba Abdulmunem Habeeb has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Asmaa H. Hammadi
Department of Pharmaceutics, College of Pharmacy, University of Babylon, Babylon, Al Hillah, Iraq
3 shared publications - Lena Fadhil Al-Jibouri
Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Babylon, Al Hillah, Iraq
2 shared publications - Amal Adnan1 shared publication
- Amer Al-Nafiey
Department of Laser Physics, College of science for women, University of Babylon, Babylon, Iraq
1 shared publication - Aymen A. Bash1 shared publication
- Dhulfiqar Ali Abed
Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ, 08854, United States
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (48) , 63981-63994
Oxytetracycline loading onto Cu–CuO/Cu 2 O nanocomposites (NCs): structural characterization and enhanced antimicrobial activity
In this study, the chemical reduction technique was utilized to create a three-phase nanocomposite system including metallic copper (Cu 0 ), cupric oxide (CuO, Cu 2+ ), and cuprous oxide (Cu 2 O, Cu + ) inside a single matrix in one step.
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (48) , 63981-63994
Open AccessOxytetracycline loading onto Cu–CuO/Cu 2 O nanocomposites (NCs): structural characterization and enhanced antimicrobial activity
In this study, the chemical reduction technique was utilized to create a three-phase nanocomposite system including metallic copper (Cu 0 ), cupric oxide (CuO, Cu 2+ ), and cuprous oxide (Cu 2 O, Cu + ) inside a single matrix in one step.
- Open Access
- 14 January 2025
- Published by Oxford University Press (OUP) in Oxford Open Materials Science
- Vol. 5 (1)
Synthesis, characterization and antibacterial activities of Ag/CuO nanocomposites
In this study, we loaded Ag with CuO NPs that had previously been synthesized using the chemical reduction technique to develop antimicrobial performance for Ag-CuO nanocomposite materials. The structure analysis, morphology, and chemical properties of Ag, CuO and Ag-CuO NPs were analyzed via Scanning Electron Microscopy analysis (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and Energy Dispersive X-ray (EDX). XRD patterns proved cubic and monoclinic phases for Ag and CuO, respectively. antibacterial activity of CuO, Ag and Ag/CuO was investigated by agar diffusion method on clinically isolated bacteria of Staphylococcus aureus and E.coli, the results indicated antibacterial effect of Ag/CuO followed by Ag then by CuO, moreover, effect of these chemicals on Gram negative bacteria (E.coli) was larger than on Gram positive bacteria (S. aureus).
- 14 January 2025
- Published by Oxford University Press (OUP) in Oxford Open Materials Science
- Vol. 5 (1)
Open AccessSynthesis, characterization and antibacterial activities of Ag/CuO nanocomposites
In this study, we loaded Ag with CuO NPs that had previously been synthesized using the chemical reduction technique to develop antimicrobial performance for Ag-CuO nanocomposite materials. The structure analysis, morphology, and chemical properties of Ag, CuO and Ag-CuO NPs were analyzed via Scanning Electron Microscopy analysis (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and Energy Dispersive X-ray (EDX). XRD patterns proved cubic and monoclinic phases for Ag and CuO, respectively. antibacterial activity of CuO, Ag and Ag/CuO was investigated by agar diffusion method on clinically isolated bacteria of Staphylococcus aureus and E.coli, the results indicated antibacterial effect of Ag/CuO followed by Ag then by CuO, moreover, effect of these chemicals on Gram negative bacteria (E.coli) was larger than on Gram positive bacteria (S. aureus).
- 5 May 2024
- Published by PHARMAKON-PRESS in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
- Vol. 38 (Sup2) , 133-136
Drug synthesis, separation, and identification of a di-stereoisomeric mixture of spiro-oxalidinonic derivatives of sorbinil by high-performance liquid chromatography
A straightforward and sensitive method for high-performance liquid chromatography (HPLC) was created in order to separate and identify the di-stereoisomeric mixture of a spiro-oxalidinonic derivative of sorbinil. HPLC was carried out using a C18 reversed-phase column. The mobile phase used in the isocratic elution process was a 70:30 v/v combi¬nation of methanol and acetonitrile flowed at a rate of 2 mL/min. The procedure delivered the best result among the various attempts made. Two peaks were identified on the chromatogram, attributable to the two di-stereoisomers of the mixture analysed. Analogues of sorbinil, a powerful inhibitor of aldose reductase, have been synthesized and further tested on aldose reductase as mixtures of di-stereoisomers, exhibiting an IC50 in the order of the micromolar. The structure of the compounds was checked with nuclear magnetic resonance spectroscopy. The chemical shifts were expressed in ppm scale δ.
- 5 May 2024
- Published by PHARMAKON-PRESS in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
- Vol. 38 (Sup2) , 133-136
Drug synthesis, separation, and identification of a di-stereoisomeric mixture of spiro-oxalidinonic derivatives of sorbinil by high-performance liquid chromatography
A straightforward and sensitive method for high-performance liquid chromatography (HPLC) was created in order to separate and identify the di-stereoisomeric mixture of a spiro-oxalidinonic derivative of sorbinil. HPLC was carried out using a C18 reversed-phase column. The mobile phase used in the isocratic elution process was a 70:30 v/v combi¬nation of methanol and acetonitrile flowed at a rate of 2 mL/min. The procedure delivered the best result among the various attempts made. Two peaks were identified on the chromatogram, attributable to the two di-stereoisomers of the mixture analysed. Analogues of sorbinil, a powerful inhibitor of aldose reductase, have been synthesized and further tested on aldose reductase as mixtures of di-stereoisomers, exhibiting an IC50 in the order of the micromolar. The structure of the compounds was checked with nuclear magnetic resonance spectroscopy. The chemical shifts were expressed in ppm scale δ.
- 5 May 2024
- Published by PHARMAKON-PRESS in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
- Vol. 38 (Sup2) , 113-116
Metronidazole-loaded zinc oxide / graphene nanoparticles: synthesis, analysis, drug delivery, and antibacterial efficiency
In our study, zinc oxide (ZnO) nanoparticles (NPs) were prepared by precipitation (economically and in high quality) at a temperature range of 60°C to 80°C and at pH 8, and were then adorned with graphene (G) plates. To determine its antimicrobial potential, the ZnO/G complex was loaded with metronidazole. The morphology and diameter of the ZnO nanocomposite before and after the loading were validated by scanning electron microscopy. The average size of the ZnO NPs was found to be 20–40 nm, while X-ray diffraction examined how the physical features of these NPs varied from those of its individual components with an average size of 28.1 nm. The assessment of the ZnO/G com¬plex’s antibacterial efficacy against Gram-positive and Gram-negative bacteria was the main aim of our work. The agar well diffusion technique was used in order to assess the antibacterial activity of the ZnO/G complex with and without metronidazole. Our study demonstrates that the ZnO/G complex possesses antibacterial activity and might increase the antibiotic action by inhibiting Gram-positive bacteria (more than Gram-negative ones). It is, therefore, concluded that the ZnO/G NPs could be of use in formulating nano-drug conjugates that could act as antimicrobial agents.
- 5 May 2024
- Published by PHARMAKON-PRESS in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
- Vol. 38 (Sup2) , 113-116
Metronidazole-loaded zinc oxide / graphene nanoparticles: synthesis, analysis, drug delivery, and antibacterial efficiency
In our study, zinc oxide (ZnO) nanoparticles (NPs) were prepared by precipitation (economically and in high quality) at a temperature range of 60°C to 80°C and at pH 8, and were then adorned with graphene (G) plates. To determine its antimicrobial potential, the ZnO/G complex was loaded with metronidazole. The morphology and diameter of the ZnO nanocomposite before and after the loading were validated by scanning electron microscopy. The average size of the ZnO NPs was found to be 20–40 nm, while X-ray diffraction examined how the physical features of these NPs varied from those of its individual components with an average size of 28.1 nm. The assessment of the ZnO/G com¬plex’s antibacterial efficacy against Gram-positive and Gram-negative bacteria was the main aim of our work. The agar well diffusion technique was used in order to assess the antibacterial activity of the ZnO/G complex with and without metronidazole. Our study demonstrates that the ZnO/G complex possesses antibacterial activity and might increase the antibiotic action by inhibiting Gram-positive bacteria (more than Gram-negative ones). It is, therefore, concluded that the ZnO/G NPs could be of use in formulating nano-drug conjugates that could act as antimicrobial agents.